1、上海市卫生健康委员会，上海市公共卫生优秀青年人才项目，GWVI-11.2-YQ51，放射性核素辐射智能监测系统构建及其应用研究，2023-07至2025-06，在研，主持。

2、上海市第十人民医院，研究型医师项目，2023YJXYSB011，内分泌性高血压病因筛查的前瞻性队列研究，2023-07至2025-12，在研，主持。

3、上海市卫生健康委员会，青年项目，20214Y0159, 基于拉曼光谱技术在肝癌肝外转移血清标志物研究, 2022-01至 2024-01, 在研, 主持。

4、 上海市第十人民医院,攀登人才计划, 2021SYPDRC065, 纳米荧光微球法检测穿刺液甲状腺球蛋白临床价值研究, 2021-01至2022-12, 结题, 主持。

5、同济大学，中央高校基本科研业务专项，22120180392，分化型甲状腺癌放射性碘耐受患者尿液中特征性miRNA的研究，2017-07至2018-08，结题，主持。

发表文章

1. Tang Jingwen,Yi Wanwan,Yan Jiahao,et al.Highly absorbent bio-sponge based on carboxymethyl chitosan/polyγ-glutamic acid/platelet-rich plasma for hemostasis and wound healing.INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.2023;247：125754.

2. Wang Ting,Yi Wanwan,Zhang Yu,et al.Sodium alginate hydrogel containing platelet-rich plasma for wound healing.COLLOIDS AND SURFACES B-BIOINTERFACES.2023;222：113096.

3. Yi Wanwan, Zhang Mengyu,Yuan XueYu,et al. A model combining testosterone, Androstenedione and free testosterone index improved the diagnostic efficiency of polycystic ovary syndrome. Endocrine Practice.2023;29(8):629-636.

4. Yi Wanwan,Jia Chengyou,Yang Ziyu,et al.Effect of umifenovir (arbidol) versus standard care on clinical outcome in patients with COVID-19: a retrospective cohort study.Therapeutic Advances in Respiratory Disease.2023;17：17534666231183811.

5. Wanwan Yi, Tingting Qiao, Ziyu Yang, Lei Hu, Mingming Sun, Hengwei Fan, Yanping Xu and Zhongwei Lv. The regulation role and diagnostic value of fifibrinogen-like protein 1 revealed by pan-cancer analysis. Materials Today Bio,2022; 12:100470.

6. Wanwan Yi, Xuan Long, Jin Liu, LiShuai Shi, Zichen Chen, Jing Yang, Ziyu Yang, Zhongwei Lv and Hengwei Fan. Risk factors for recurrent positive results of the nucleic acid amplification test for COVID-19 patients: a retrospective study. Human Cell, 2021;34 (6):1744-1754.

7. Ru Wang, Hengwei Fan, Ming Sun, Zhongwei Lv and Wanwan Yi. Roles of BMI1 in the Initiation, Progression,and Treatment of Hepatocellular Carcinoma.Technology in Cancer Research & Treatment, 2022;21:15330338211070689.

8.Wanwan Yi, Jin Liu, Shuping Qu, Hengwei Fan and Zhongwei Lv.An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.Technology in Cancer Research & Treatment, 2020;19:1533033820965594.

9. Hengwei Fan, Xiaqing Yu, Xiaohui Fu, Hengmei Zhu, Zhongwei Lv, Wanwan Yi and Qian Zhang.Clinical implications of different specimen types for nucleic acid testing in two cases of COVID-19.Journal of International Medical Research, 2020;48(8):300060520949067.

10. Shuping Qu, Qiuyuan Shi, Jing Xu, Wanwan Yi and Hengwei Fan.Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma.Evolutionary Bioinformatics,2020;16:1176934320920562.

11. Lu Hai-Min,Yi Wan-Wan, Ma Yu-Shui,et al.Prognostic implications of decreased microRNA-101-3p expression in patients with non-small cell lung cancer.Oncology Letters, 2018;16 (6):7048-7056.

12. Zhang Chao, Fan Heng-Wei, Yi Wan-Wan and Zhi-Qiang Zheng. Hidden Blood Loss and Its Influential Factors After Laparoscopy-Assisted Gastrectomy for Gastric Cancer. Journal of Laparoendoscopic & Advanced Surgical Techniques, 2018;28 (3):237-241.

13. Zhang Yijun, Qu Shuping, Yi Wanwan, et al. A Pretreatment CT Model Predicts Survival Following Chemolipiodolization in Patients With Hepatocellular Carcinoma.Technology in Cancer Research & Treatment, 2019;18：1533033819844488.

14. Xie WenTing, Zhang Han, Qin ShanShan, JiaJia Zhang, Xin Fan, YuZhen Yin, RuiPeng Liang, HuiDeng Long, WanWan Yi, Da Fu, Chao Ma, MingLi Lv and Fei Yu.The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.GENE.2019;720:144088.

15. Yang Mengdie, Yin Yuzhen, Zhang Jiajia, Yi, Wanwan, et al. Cytokines: Application in recurrence appraisal for differentiated thyroid carcinoma and their relation with radioiodine ablation.Journal of cellular biochemistry.2021;122 (10):1350-1359.

16. Long Xuan, Zhang Jie, Chen Jia, Shi Lishuai, Li Xuan, Yi Wanwan, Chen Zichen, Kosasih Sinthu,Yu Zhen, Mei Aihong and Wang Changhui. Analyzing the influence of COVID-19 epidemic on the employment intention of resident physicians in China.Journal of infection in developing countries.2022;16 (6):1009-1015.

17. 易婉婉,史秋园,陈从艳,袁芳,吕中伟.同位素稀释超高效液相色谱串联质谱法快速检测血清中多种脂溶性维生素含量[J].中华核医学与分子影像杂志,2020,10(40):599-602.

18. 易婉婉,袁雪宇,蔡海东,刘瑾,张倩,范素云,吕中伟.131I治疗分化型甲状腺癌术后患者辐射剂量预测模型的研究[J].国际放射医学核医学杂志,2022,2(46):67-73.

19. 易婉婉,孙奋勇.慢性乙型肝炎外周血T淋巴细胞亚群变化的Meta分析[J].蚌埠医学院学报,2016,41(04):438-444.

20. 易婉婉,崔培元,范恒伟,谈燚,吴华,吴斌全,吴维.胰十二指肠切除术72例围手术期治疗[J].蚌埠医学院学报,2014,39(02):171-173.

21. 钟鹏,郁霞青,陈志刚,易婉婉,贾成友,吕中伟.NSCLC患者尿液中游离miRNAs qPCR内参基因的选择[J].同济大学学报(医学版),2019,40(04):419-424.

获得奖项

2018年荣获先进医务工作者称号

2020年荣获“上海市科技进步一等奖”

2023年荣获“研究型医师”

2023年荣获“江苏医药科技奖二等奖”

授权专利

1、发明专利：加样枪避免倒吸入枪体的装置，2022-07-26，ZL202110689051.X（第1发明人）

2、发明专利：自动去除加样样品中气泡的加样枪，2022-09-16，ZL202110695939.4（第1发明人）

3、实用新型专利：一种可自动更换枪头的加样枪，2021-11-05，ZL202120182705.5（第1发明人）

4、 实用新型专利：一种排枪枪头更换辅助装置，2021-11-05，ZL202120167502.9 （第1发明人）

5、 发明专利：一种检测血液样品中脂溶性维生素的方法，2021-01-15，ZL201910799963.5（第6发明人）

6、实用新型：一种离心管，2021-05-12，ZL202121011367.5  （第6发明人）